Potential drug therapy for kidney stones identified in mouse study
8/19/2014
Anyone who has suffered from kidney stones is keenly aware of the lack of drugs to treat the condition, which often causes excruciating pain.
New ways to treat solid tumours
8/19/2014
An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumour effects.
Vanderbilt investigators have discovered a novel treatment that strengthens bones in neurofibromatosis type-1.
Older patients with limited life expectancy still receiving cancer screenings
8/18/2014
A substantial number of older patients with limited life expectancy continue to receive routine screenings for prostate, breast, cervical and colorectal cancer although the procedures are unlikely...
Tumors shrink following bacteria injection
8/18/2014
Tumors in rats, dogs and one human patient shrank after being injected with spores of a mutant version of a soil bacterium that thrives only in oxygen-poor environments.
NICE rejection of abiraterone before chemotherapy in advanced prostate cancer
8/18/2014
Janssen statement in response to the NICE Final Appraisal Determination (FAD) on the use of Zytiga® (abiraterone acetate) prior to chemotherapyJanssen is extremely disappointed with the...
FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
8/18/2014
The U.S. Food and Drug Administration today approved a new use for Avastin (bevacizumab) to treat patients with persistent, recurrent or late-stage (metastatic) cervical cancer.
Gene regulation manipulated to switch off sickle cell disease
8/18/2014
Scientists have altered key biological events in red blood cells, causing the cells to produce a form of hemoglobin normally absent after the newborn period.
Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all steps of the clinical trial are most likely to undergo a biopsy, according to a study published in...
Potential to stop cancer metastasis following immune cell discovery
8/18/2014
Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs.